Indeed, HSP60 is actively secreted by tumor cells, most probably through the exosomal pathway [15], and titers of antibodies against HSP60 were reported to be higher in CRC patients than in controls [43]. The gene discussed is HSPD1; the disease is colorectal carcinoma.